光子计数探测器CT的肝脏碘定量:腹部体模中的准确性与患者中的可行性
研究在腹部体模中比较双源光子计数探测器CT(PCD-CT)与双源能量积分探测器CT(EID-CT)对肝实质和病灶碘定量的准确性,并回顾性纳入30例肝囊肿、血管瘤或转移瘤患者验证PCD-CT的可行性。体模中PCD-CT与EID-CT的碘误差无显著差异(p>0.05),PCD-CT的误差不受辐射剂量、碘浓度和基材衰减影响;患者中肝实质及常见肝病灶的碘定量可行。
要点
- PCD-CT在体模中对肝实质和病灶的碘定量误差与EID-CT无显著差异(p>0.05)。
- PCD-CT的碘定量误差不受辐射剂量、碘浓度和基材衰减的显著影响(p>0.05)。
- 患者中PCD-CT对肝实质、囊肿、血管瘤和转移瘤的碘定量均可行。
核心结论
- PCD-CT在模拟肝实质和病灶中的碘定量准确,不受辐射剂量、碘浓度和基材衰减影响,且在患者常见肝病灶中可行。
研究设计与样本
- 体模研究加回顾性患者研究;体模为含肝实质和病灶插件的腹部仿真体模,在临床PCD-CT(120kV)和EID-CT双能模式(80/Sn150kV、90/Sn150kV、100/Sn150kV)下成像,三种患者尺寸、三种辐射剂量(CTDIvol:5、10、15mGy);回顾性纳入30例肝囊肿、血管瘤或转移瘤患者,以厂商规格为参考标准计算碘误差。
诊断标准与关键数值
- 体模整体碘误差:EID-CT 80/Sn150kV为0.33±0.29 mgI/mL,90/Sn150kV为0.34±0.32 mgI/mL,100/Sn150kV为0.39±0.37 mgI/mL,PCD-CT为0.35±0.39 mgI/mL,PCD-CT与EID-CT间无显著差异(p>0.05)。
临床应用与阅片要点
- 患者中PCD-CT碘定量在肝实质、囊肿、血管瘤和转移瘤中均可行;体模中较小患者尺寸与较低误差相关(p<0.05),EID-CT的碘定量受碘浓度和基材衰减显著影响(p<0.05),PCD-CT不受影响(p>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To compare the accuracy of iodine quantification in liver parenchyma and lesions between dual-source photon-counting detector CT (PCD-CT) and dual-source energy-integrating detector CT (EID-CT) in a phantom and to demonstrate the feasibility of iodine quantification with PCD-CT in liver parenchyma and lesions in patients.
MATERIALS AND METHODS: An anthropomorphic abdominal phantom with a liver insert containing parenchyma and lesions was imaged on a clinical PCD-CT at 120kV and in the dual-energy mode on an EID-CT with kV-combinations of 80/Sn150kV, 90/Sn150kV, and 100/Sn150kV. Three patient sizes were imaged at three different radiation doses (CTDIvol: 5, 10, 15mGy). Thirty patients with liver cysts, hemangiomas or metastases imaged with PCD-CT were retrospectively included. Iodine maps were reconstructed and iodine concentrations were measured in liver parenchyma and lesions. For the phantom, iodine error was quantified as the absolute difference to the vendor's specifications as reference.
RESULTS: Overall iodine error was 0.33 ± 0.29, 0.34 ± 0.32, 0.39 ± 0.37, 0.35 ± 0.39 mgI/mL for 80/Sn150kV, 90/Sn150kV, 100/Sn150kV of EID-CT, and PCD-CT, respectively, without significant differences between PCD-CT and EID-CT (p > 0.05). Radiation dose did not significantly influence error of PCD-CT (p > 0.05) nor EID-CT (p > 0.05). For both scanners, smaller patient sizes were associated with lower errors (p < 0.05). Iodine concentration and base material attenuation significantly influenced quantification for EID-CT (p < 0.05) but not PCD-CT (p > 0.05). In patients, iodine quantification was feasible in liver parenchyma, cysts, hemangiomas, and metastases.
CONCLUSION: Iodine quantification with PCD-CT is accurate in simulated liver parenchyma and lesions irrespective of radiation dose, iodine concentration, and base attenuation and is feasible in common liver lesions in patients.
引用
- Sartoretti, Mergen, Jungblut, et al. Liver Iodine Quantification With Photon-Counting Detector CT: Accuracy in an Abdominal Phantom and Feasibility in Patients. Acad Radiol. 2022. PMID: 35644755. doi:10.1016/j.acra.2022.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。